Atlas Trials

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients

Clinical trial NCT04001608 · UNKNOWN

Trial details

NCT number
NCT04001608
Sponsor
Ginkgopharma CO., LTD
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C Virus Infection
Start date
2018-10-17
Primary completion
2019-07-31
Enrollment
206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.